Trial
NCT03574818
Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Montefiore Medical Center
Collaborators
Eli Lilly and Company
Condition
Squamous Cell Lung Cancer
Intervention
Necitumumab-Gemcitabine-Cisplatin
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-18